Vimarsana
Biggest News Aggregation in the World

Richard Bazinet News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Richard Bazinet. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Richard Bazinet Today - Breaking & Trending Today

Updated News -Research Flags Stroke Risk from Omega-3 Fish Oil Supplements - Vimarsana News

Updated News -Research Flags Stroke Risk from Omega-3 Fish Oil Supplements

Fish oil supplements, commonly used during pregnancy and for enhancing cardiovascular and brain health, may increase the risk of heart problems and stroke, new research suggests. A study from the United Kingdom, published in the British Medical Journal, found that regular use of fish oil supplements is linked to a higher risk of stroke and…

Study Findings Suggest Liver Creates Palmitic Acid, Maintaining Brain Health - Vimarsana News

Study Findings Suggest Liver Creates Palmitic Acid, Maintaining Brain Health

The results from the preclinical trial can provide a new method of measuring dietary sources of nutrients in the tissue, but further research is needed to confirm the findings in the human brain.

Ahiflower Oil matches marine DHA for tissue DHA needs: Study - Vimarsana News

Ahiflower Oil matches marine DHA for tissue DHA needs: Study

Ahiflower oil may form newly synthesized omega-3 DHA (docosahexaenoic acid) and replace it in key tissues like liver, adipose, and the brain in mice with comparable efficiency as ‘preformed’ DHA from fish.

Ahiflower Oil matches marine DHA for tissue DHA needs: Study - Vimarsana News

Ahiflower Oil matches marine DHA for tissue DHA needs: Study

Ahiflower oil may form newly synthesized omega-3 DHA (docosahexaenoic acid) and replace it in key tissues like liver, adipose, and the brain in mice with comparable efficiency as ‘preformed’ DHA from fish.

GoodCap Pharmaceuticals Inc.: GoodCap Pharmaceuticals and the University of Toronto Awarded NSERC Alliance Grant for Ongoing Research of Low-Dose Psilocybin Drug Formulas Targeting Inflammation and Depressive Disorders - Vimarsana News

GoodCap Pharmaceuticals Inc.: GoodCap Pharmaceuticals and the University of Toronto Awarded NSERC Alliance Grant for Ongoing Research of Low-Dose Psilocybin Drug Formulas Targeting Inflammation and Depressive Disorders

Toronto, Ontario--(Newsfile Corp. - November 10, 2022) - GoodCap Pharmaceuticals Inc. ("GoodCap" or the "Company"), a biopharmaceutical company developing low-dose psychedelic therapies, is pleased to